These novel plaque proteins are associated with crucial processes in Alzheimer's neuropathology and DS including lysosomal functions (ACP2, LAMTOR4), immune response (HLA-DRB5, IL36G), and ubiquitination (RBX1) (49–55). Here, HLA-DRB5 is linked to Dravet syndrome.